Overview

Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males.

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
Phase 1 Dose Escalating Study of the safety, tolerability and pharmacokinetics of testosterone in hypogonadal males.
Phase:
Phase 1
Details
Lead Sponsor:
Abbott
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate